In a memo to Dr Walford, Dr Fowler expressed concerns that US manufacturers "may try to dump blood products produced from plasma collected prior to the March 1983 FDA regulations on the UK market."
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Diana Walford
Dr L K Fowler